))
Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin
Manage episode 436314847 series 3570618
Content provided by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izokibep, a novel IL-17A inhibitor, for HS, and more.
The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!
9 episodes
Share
